Immunoregulatory networks in human Chagas disease

Chagas disease, caused by the infection with Trypanosoma cruzi, is endemic in all Latin America. Due to the increase in population migration, Chagas disease has spread worldwide and is now considered a health issue not only in endemic countries. While most chronically infected individuals remain asymptomatic, approximately 30% of the patients develop a potentially deadly cardiomyopathy. The exact mechanisms that underlie the establishment and maintenance of the cardiac pathology are not clear. However, there is consistent evidence that immunoregulatory cytokines are critical for orchestrating the immune response and thus influence disease development or control. While the asymptomatic (indeterminate) form represents a state of balance between the host and the parasite, the establishment of the cardiac form represents the loss of this balance. Analysis of data obtained from several studies has led to the hypothesis that the indeterminate form is associated with an anti‐inflammatory cytokine profile, represented by high expression of IL‐10, while cardiac form is associated with a high production of IFN‐gamma and TNF‐alpha in relation to IL‐10, leading to an inflammatory profile. Here, we discuss the immunoregulatory events that might influence disease outcome, as well as the mechanisms that influence the establishment of these complex immunoregulatory networks.

[1]  K. Gollob,et al.  Low levels of vasoactive intestinal peptide are associated with Chagas disease cardiomyopathy. , 2013, Human immunology.

[2]  I. Mendoza,et al.  ECG Manifestations of the Biggest Outbreak of Chagas Disease due to Oral Infection in Latin-America , 2013, Arquivos brasileiros de cardiologia.

[3]  O. Campetella,et al.  Differential Distribution of Genes Encoding the Virulence Factor Trans-Sialidase along Trypanosoma cruzi Discrete Typing Units , 2013, PloS one.

[4]  M. C. Nunes,et al.  High interleukin 17 expression is correlated with better cardiac function in human Chagas disease. , 2013, The Journal of infectious diseases.

[5]  S. Adad,et al.  An imbalance between substance P and vasoactive intestinal polypeptide might contribute to the immunopathology of megaesophagus after Trypanosoma cruzi infection. , 2013, Human pathology.

[6]  R. Fujiwara,et al.  Regenerative process evaluation of neuronal subclasses in chagasic patients with megacolon. , 2013, Human immunology.

[7]  A. Fontenot,et al.  Highly conserved CDR3 region in circulating CD4+Vβ5+ T cells may be associated with cytotoxic activity in Chagas disease , 2012, Clinical and experimental immunology.

[8]  A. Teixeira-Carvalho,et al.  Foxp3+CD25(high) CD4+ regulatory T cells from indeterminate patients with Chagas disease can suppress the effector cells and cytokines and reveal altered correlations with disease severity. , 2012, Immunobiology.

[9]  E. C. Oliveira,et al.  Preponderance of inhibitory versus excitatory intramuscular nerve fibres in human chagasic megacolon , 2012, International Journal of Colorectal Disease.

[10]  E. C. Oliveira,et al.  Selective survival of calretinin- and vasoactive-intestinal-peptide-containing nerve elements in human chagasic submucosa and mucosa , 2012, Cell and Tissue Research.

[11]  F. A. Martins,et al.  IFN-γ Plays a Unique Role in Protection against Low Virulent Trypanosoma cruzi Strain , 2012, PLoS neglected tropical diseases.

[12]  M. Llewellyn,et al.  The revised Trypanosoma cruzi subspecific nomenclature: rationale, epidemiological relevance and research applications. , 2012, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[13]  S. Montgomery,et al.  Trypanosoma cruzi and Chagas' Disease in the United States , 2011, Clinical Microbiology Reviews.

[14]  F. H. Santello,et al.  Prolactin: does it exert an up-modulation of the immune response in Trypanosoma cruzi-infected rats? , 2011, Veterinary parasitology.

[15]  D. Pena,et al.  Selection of TcII Trypanosoma cruzi population following macrophage infection. , 2011, The Journal of infectious diseases.

[16]  S. D. Silva-Barbosa,et al.  Immunoneuroendocrine alterations in patients with progressive forms of chronic Chagas disease , 2011, Journal of Neuroimmunology.

[17]  J. Scharfstein,et al.  Captopril increases the intensity of monocyte infection by Trypanosoma cruzi and induces human T helper type 17 cells , 2010, Clinical and experimental immunology.

[18]  S. D. Pena,et al.  Differential tissue tropism of Trypanosoma cruzi strains: an in vitro study. , 2010, Memorias do Instituto Oswaldo Cruz.

[19]  M. C. Nunes,et al.  Trypanosoma cruzi-Induced Activation of Functionally Distinct αβ and γδ CD4− CD8− T Cells in Individuals with Polar Forms of Chagas' Disease , 2010, Infection and Immunity.

[20]  Y. Iwakura,et al.  IL-17 Is Necessary for Host Protection against Acute-Phase Trypanosoma cruzi Infection , 2010, The Journal of Immunology.

[21]  J. Coura,et al.  Chagas disease: a new worldwide challenge , 2010, Nature.

[22]  K. Maemura,et al.  Lineage Analysis of Circulating Trypanosoma cruzi Parasites and Their Association with Clinical Forms of Chagas Disease in Bolivia , 2010, PLoS neglected tropical diseases.

[23]  J. Silva,et al.  IL-17 Produced during Trypanosoma cruzi Infection Plays a Central Role in Regulating Parasite-Induced Myocarditis , 2010, PLoS neglected tropical diseases.

[24]  A. Romanha,et al.  A new consensus for Trypanosoma cruzi intraspecific nomenclature: second revision meeting recommends TcI to TcVI. , 2009, Memorias do Instituto Oswaldo Cruz.

[25]  A. Krettli The utility of anti-trypomastigote lytic antibodies for determining cure of Trypanosoma cruzi infections in treated patients: an overview and perspectives. , 2009, Memorias do Instituto Oswaldo Cruz.

[26]  C. R. Machado,et al.  Probing Population Dynamics of Trypanosoma cruzi during Progression of the Chronic Phase in Chagasic Patients , 2009, Journal of Clinical Microbiology.

[27]  G. Franco,et al.  The MHC Gene Region of Murine Hosts Influences the Differential Tissue Tropism of Infecting Trypanosoma cruzi Strains , 2009, PloS one.

[28]  K. Gollob,et al.  Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. , 2009, The Journal of infectious diseases.

[29]  A. Teixeira-Carvalho,et al.  Strategy to Assess the Overall Cytokine Profile of Circulating Leukocytes and its Association with Distinct Clinical Forms of Human Chagas Disease , 2008, Scandinavian journal of immunology.

[30]  R. Corrêa-Oliveira,et al.  Substance P and NK1 receptor expression in the enteric nervous system is related to the development of chagasic megacolon. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[31]  J. Scharfstein,et al.  Bradykinin B2 Receptors of Dendritic Cells, Acting as Sensors of Kinins Proteolytically Released by Trypanosoma cruzi, Are Critical for the Development of Protective Type-1 Responses , 2007, PLoS pathogens.

[32]  A. Ribeiro,et al.  An update on the management of Chagas cardiomyopathy , 2007, Expert review of anti-infective therapy.

[33]  S. Williams-Blangero,et al.  Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease. , 2007, Frontiers in bioscience : a journal and virtual library.

[34]  E. C. Oliveira,et al.  Neurochemical Coding of the Enteric Nervous System in Chagasic Patients with Megacolon , 2007, Digestive Diseases and Sciences.

[35]  C. Carneiro,et al.  Trypanosoma cruzi high infectivity in vitro is related to cardiac lesions during long-term infection in Beagle dogs. , 2007, Memorias do Instituto Oswaldo Cruz.

[36]  E. Segura,et al.  Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina , 2006, Current opinion in infectious diseases.

[37]  Á. Moncayo,et al.  An update on Chagas disease (human American trypanosomiasis) , 2006, Annals of tropical medicine and parasitology.

[38]  Alessandro Sette,et al.  CD8+ T-Cell Responses to Trypanosoma cruzi Are Highly Focused on Strain-Variant trans-Sialidase Epitopes , 2006, PLoS pathogens.

[39]  U. Renner,et al.  Hypothalamus–pituitary–adrenal axis during Trypanosoma cruzi acute infection in mice , 2006, Journal of Neuroimmunology.

[40]  I. Watanabe,et al.  Trypanosoma cruzi: preliminary investigation of NADH-positive and somatostatin-immunoreactive neurons in the myenteric plexus of the mouse colon during the infection. , 2005, Experimental parasitology.

[41]  M. M. Teixeira,et al.  Predominance of lineage I among Trypanosoma cruzi isolates from Venezuelan patients with different clinical profiles of acute Chagas’ disease , 2004, Tropical medicine & international health : TM & IH.

[42]  M. O. Rocha,et al.  Monocytes from Patients with Indeterminate and Cardiac Forms of Chagas' Disease Display Distinct Phenotypic and Functional Characteristics Associated with Morbidity , 2004, Infection and Immunity.

[43]  D. Pozo,et al.  The many faces of VIP in neuroimmunology: a cytokine rather a neuropeptide? , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  A. Ribeiro,et al.  Elevated Concentrations of CCL2 and Tumor Necrosis Factor—α in Chagasic Cardiomyopathy , 2004 .

[45]  R. Tarleton,et al.  Frequency of interferon- gamma -producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. , 2004, The Journal of infectious diseases.

[46]  S. D. Pena,et al.  Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of chagas disease. , 2004, Memórias do Instituto Oswaldo Cruz.

[47]  A. Teixeira-Carvalho,et al.  Phenotypic Features of Peripheral Blood Leucocytes During Early Stages of Human Infection with Trypanosoma cruzi , 2003, Scandinavian journal of immunology.

[48]  C. Machado,et al.  Trypanosoma cruzi: mixture of two populations can modify virulence and tissue tropism in rat. , 2003, Experimental parasitology.

[49]  R. Corrêa-Oliveira,et al.  Evidence that Development of Severe Cardiomyopathy in Human Chagas' Disease Is Due to a Th1-Specific Immune Response , 2003, Infection and Immunity.

[50]  E. Douzery,et al.  Evidence for genetic exchange and hybridization in Trypanosoma cruzi based on nucleotide sequences and molecular karyotype. , 2003, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[51]  R. Gazzinelli,et al.  Chemokines, inflammation and Trypanosoma cruzi infection. , 2002, Trends in parasitology.

[52]  A. Todeschini,et al.  Costimulation of Host T Lymphocytes by a Trypanosomal trans-Sialidase: Involvement of CD43 Signaling1 , 2002, The Journal of Immunology.

[53]  F. Noireau,et al.  Integrate study of a Bolivian population infected by Trypanosoma cruzi, the agent of Chagas disease. , 2002, Memorias do Instituto Oswaldo Cruz.

[54]  A. Frasch,et al.  A Trypanosoma cruzi Small Surface Molecule Provides the First Immunological Evidence that Chagas' Disease Is Due to a Single Parasite Lineage , 2002, The Journal of experimental medicine.

[55]  S. Brisse,et al.  Characterisation of large and small subunit rRNA and mini-exon genes further supports the distinction of six Trypanosoma cruzi lineages. , 2001, International journal for parasitology.

[56]  C. Mady,et al.  Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. , 2001, Journal of autoimmunity.

[57]  S. Brisse,et al.  Identification of six Trypanosoma cruzi lineages by sequence-characterised amplified region markers. , 2000, Molecular and biochemical parasitology.

[58]  S. D. Pena,et al.  Genetic characterization of Trypanosoma cruzi directly from tissues of patients with chronic Chagas disease: differential distribution of genetic types into diverse organs. , 2000, The American journal of pathology.

[59]  Brener,et al.  Self and Nonself Stimulatory Molecules Induce Preferential Expansion of CD5+ B Cells or Activated T Cells of Chagasic Patients, Respectively , 2000, Scandinavian journal of immunology.

[60]  B. Zingales,et al.  Epidemiology, biochemistry and evolution of Trypanosoma cruzi lineages based on ribosomal RNA sequences. , 1999, Memorias do Instituto Oswaldo Cruz.

[61]  M. Tibayrenc,et al.  Trypanosoma cruzi: compared vectorial transmissibility of three major clonal genotypes by Triatoma infestans. , 1998, Experimental parasitology.

[62]  M. Tibayrenc,et al.  Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. , 1998, Experimental parasitology.

[63]  M. Tibayrenc,et al.  Compared vectorial transmissibility of pure and mixed clonal genotypes of Trypanosoma cruzi in Triatoma infestans , 1998, Parasitology Research.

[64]  S. D. Pena,et al.  Genetic Variability of Trypanosoma cruzi:Implications for the Pathogenesis of Chagas Disease. , 1998, Parasitology today.

[65]  F. Pileggi,et al.  Association of an increase in CD8+ T cells with the presence of Trypanosoma cruzi antigens in chronic, human, chagasic myocarditis. , 1997, The American journal of tropical medicine and hygiene.

[66]  M. Tibayrenc,et al.  Impact of clonal evolution on the biological diversity of Trypanosoma cruzi , 1997, Parasitology.

[67]  M. Lazarus,et al.  An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.

[68]  R. Coffman,et al.  Cytokine mRNA Profile of Peripheral Blood Mononuclear Cells Isolated from Individuals with Trypanosoma cruzi Chronic Infection , 1997, Scandinavian journal of immunology.

[69]  J. Aliberti,et al.  Tumor necrosis factor alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric oxide production in infected gamma interferon-activated macrophages , 1995, Infection and immunity.

[70]  E. Jones,et al.  Characterization of inflammatory infiltrates in chronic chagasic myocardial lesions: presence of tumor necrosis factor-alpha+ cells and dominance of granzyme A+, CD8+ lymphocytes. , 1993, The American journal of tropical medicine and hygiene.

[71]  M. Miles,et al.  DO RADICALLY DISSIMILAR TRYPANOSOMA CRUZI STRAINS (ZYMODEMES) CAUSE VENEZUELAN AND BRAZILIAN FORMS OF CHAGAS' DISEASE? , 1981, The Lancet.

[72]  D. Taub Neuroendocrine interactions in the immune system. , 2008, Cellular immunology.

[73]  M. Soares,et al.  Characterization of Trypanosoma cruzi isolated from humans, vectors, and animal reservoirs following an outbreak of acute human Chagas disease in Santa Catarina State, Brazil. , 2008, Diagnostic microbiology and infectious disease.

[74]  R. Glaser,et al.  Stress hormones and immune function. , 2008, Cellular immunology.

[75]  A. Rassi,et al.  Specific treatment for Trypanosoma cruzi: lack of efficacy of allopurinol in the human chronic phase of Chagas disease. , 2007, The American journal of tropical medicine and hygiene.

[76]  G. Vargas-Alarcón,et al.  MHC class I and class II genes in Mexican patients with Chagas disease. , 2004, Human immunology.

[77]  A. Ribeiro,et al.  Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[78]  S. Brisse,et al.  Identification of six Trypanosoma cruzi phylogenetic lineages by random amplified polymorphic DNA and multilocus enzyme electrophoresis. , 2000, International journal for parasitology.

[79]  R. Coffman,et al.  IFN-gamma in human Chagas' disease: protection or pathology? , 1998, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[80]  M. Tibayrenc Genetic epidemiology of parasitic protozoa and other infectious agents: the need for an integrated approach. , 1998, International journal for parasitology.

[81]  M. Tibayrenc Kinetoplastid Biology and Disease Genetic Subdivisions within Trypanosoma Cruzi (discrete Typing Units) and Their Relevance for Molecular Epidemiology and Experimental Evolution , 2022 .